NDC 54868-0061

NDC 54868-0061

NDC 54868-0061 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 54868-0061
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 54868-0061-5 [54868006105]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-12-20
Inactivation Date2019-09-24

NDC 54868-0061-3 [54868006103]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-12-20
Inactivation Date2019-09-24

NDC 54868-0061-4 [54868006104]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-12-20
Inactivation Date2019-09-24

NDC 54868-0061-6 [54868006106]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-07-26
Inactivation Date2019-09-24

NDC 54868-0061-2 [54868006102]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-12-20
Inactivation Date2019-09-24

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.